Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin [clinicaltrials:NCT00004005]
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin [clinicaltrials:NCT00004005]
Bio2RDF identifier
NCT00004005
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00004005
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... r) of unknown primary origin.
brief title [clinicaltrials_vocabulary:brief-title]
Irinotecan Followed By Fluorou ...... cer) of Unknown Primary Origin
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2005-10-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
- ...... or this study within 4 years.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
adenocarcinoma of unknown primary
newly diagnosed carcinoma of unknown primary
recurrent carcinoma of unknown primary
stage III colon cancer
stage III rectal cancer
stage IV colon cancer
stage IV rectal cancer
unspecified adult solid tumor, protocol specific
unspecified childhood solid tumor, protocol specific
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-10-03T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00004005
official title [clinicaltrials_vocabulary:official-title]
Irinotecan and 5-Fluorouracil/ ...... ma and Other Refractory Tumors
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000067216
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2005-10-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
P30CA021765
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-10-01T00:00:00Z
identifier
clinicaltrials:NCT00004005
title
Irinotecan Followed By Fluorou ...... cer) of Unknown Primary Origin
@en
type
label
Irinotecan Followed By Fluorou ...... n [clinicaltrials:NCT00004005]
@en